Prognostic analysis of inflammatory response-related genes and biomarkers in patients with urothelial carcinoma of ureter

Ureteral urothelial carcinoma is a common urinary system tumor, accounting for 40% to 60% of all ureteral diseases. This study attempted to analyze the prognosis of patients with urothelial carcinoma, judging ureteral urothelial carcinoma by genes and biomarkers of inflammatory response. In this pap...

Full description

Bibliographic Details
Main Authors: Huaian Chen, Shuo Liu, Xiujun Li, Zhe Wang, Chao Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2023.1139412/full
_version_ 1811161719488118784
author Huaian Chen
Shuo Liu
Xiujun Li
Zhe Wang
Chao Zhang
author_facet Huaian Chen
Shuo Liu
Xiujun Li
Zhe Wang
Chao Zhang
author_sort Huaian Chen
collection DOAJ
description Ureteral urothelial carcinoma is a common urinary system tumor, accounting for 40% to 60% of all ureteral diseases. This study attempted to analyze the prognosis of patients with urothelial carcinoma, judging ureteral urothelial carcinoma by genes and biomarkers of inflammatory response. In this paper, co-expression network analysis and gene-based image fusion evaluation methods were proposed to obtain the prognosis results of patients with ureteral urothelial carcinoma. The experimental results showed that the levels of PLR and NLR increased, and the levels of HGB and HCT decreased; high PLR and high NLR levels, low HGB and low HCT levels were all risk factors affecting bladder urothelial carcinoma, and their ratios (OR) were 1.023, 1.611, 0.961, 0.859, 1.015, 1.072, 0.979, and 0.951, respectively. However, high PLR and high NLR levels were independent risk factors for bladder urothelial carcinoma, and their OR values were 1.497 and 1.071, respectively. Through biomarker diagnosis, the area under the curve, sensitivity, specificity and Youden index of hsa-mir-17, hsa-mir-93, hsa-mir-429 and hsa-mir-20a all exceeded 0.9, indicating that this is a potential diagnostic indicators. All in all, during the treatment of ureteral cancer, in order to reduce tumor recurrence, systemic therapy should be combined with ureteral cancer. In addition, this study also analyzed the prognosis of chemotherapy patients, and the results showed that immunotherapy may increase the risk of tumor cell reperfusion during chemotherapy.
first_indexed 2024-04-10T06:18:56Z
format Article
id doaj.art-dcf534c188124cd4be9cc101fef2b4e4
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-04-10T06:18:56Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-dcf534c188124cd4be9cc101fef2b4e42023-03-02T05:28:21ZengFrontiers Media S.A.Frontiers in Genetics1664-80212023-03-011410.3389/fgene.2023.11394121139412Prognostic analysis of inflammatory response-related genes and biomarkers in patients with urothelial carcinoma of ureterHuaian ChenShuo LiuXiujun LiZhe WangChao ZhangUreteral urothelial carcinoma is a common urinary system tumor, accounting for 40% to 60% of all ureteral diseases. This study attempted to analyze the prognosis of patients with urothelial carcinoma, judging ureteral urothelial carcinoma by genes and biomarkers of inflammatory response. In this paper, co-expression network analysis and gene-based image fusion evaluation methods were proposed to obtain the prognosis results of patients with ureteral urothelial carcinoma. The experimental results showed that the levels of PLR and NLR increased, and the levels of HGB and HCT decreased; high PLR and high NLR levels, low HGB and low HCT levels were all risk factors affecting bladder urothelial carcinoma, and their ratios (OR) were 1.023, 1.611, 0.961, 0.859, 1.015, 1.072, 0.979, and 0.951, respectively. However, high PLR and high NLR levels were independent risk factors for bladder urothelial carcinoma, and their OR values were 1.497 and 1.071, respectively. Through biomarker diagnosis, the area under the curve, sensitivity, specificity and Youden index of hsa-mir-17, hsa-mir-93, hsa-mir-429 and hsa-mir-20a all exceeded 0.9, indicating that this is a potential diagnostic indicators. All in all, during the treatment of ureteral cancer, in order to reduce tumor recurrence, systemic therapy should be combined with ureteral cancer. In addition, this study also analyzed the prognosis of chemotherapy patients, and the results showed that immunotherapy may increase the risk of tumor cell reperfusion during chemotherapy.https://www.frontiersin.org/articles/10.3389/fgene.2023.1139412/fullpatients with urothelial carcinoma of ureterinflammatory reactionrelated genesprognostic analysisimage fusion
spellingShingle Huaian Chen
Shuo Liu
Xiujun Li
Zhe Wang
Chao Zhang
Prognostic analysis of inflammatory response-related genes and biomarkers in patients with urothelial carcinoma of ureter
Frontiers in Genetics
patients with urothelial carcinoma of ureter
inflammatory reaction
related genes
prognostic analysis
image fusion
title Prognostic analysis of inflammatory response-related genes and biomarkers in patients with urothelial carcinoma of ureter
title_full Prognostic analysis of inflammatory response-related genes and biomarkers in patients with urothelial carcinoma of ureter
title_fullStr Prognostic analysis of inflammatory response-related genes and biomarkers in patients with urothelial carcinoma of ureter
title_full_unstemmed Prognostic analysis of inflammatory response-related genes and biomarkers in patients with urothelial carcinoma of ureter
title_short Prognostic analysis of inflammatory response-related genes and biomarkers in patients with urothelial carcinoma of ureter
title_sort prognostic analysis of inflammatory response related genes and biomarkers in patients with urothelial carcinoma of ureter
topic patients with urothelial carcinoma of ureter
inflammatory reaction
related genes
prognostic analysis
image fusion
url https://www.frontiersin.org/articles/10.3389/fgene.2023.1139412/full
work_keys_str_mv AT huaianchen prognosticanalysisofinflammatoryresponserelatedgenesandbiomarkersinpatientswithurothelialcarcinomaofureter
AT shuoliu prognosticanalysisofinflammatoryresponserelatedgenesandbiomarkersinpatientswithurothelialcarcinomaofureter
AT xiujunli prognosticanalysisofinflammatoryresponserelatedgenesandbiomarkersinpatientswithurothelialcarcinomaofureter
AT zhewang prognosticanalysisofinflammatoryresponserelatedgenesandbiomarkersinpatientswithurothelialcarcinomaofureter
AT chaozhang prognosticanalysisofinflammatoryresponserelatedgenesandbiomarkersinpatientswithurothelialcarcinomaofureter